Literature DB >> 10675682

Preparation and characterization of Furosemide-Eudragit controlled release systems.

J M Aceves1, R Cruz, E Hernandez.   

Abstract

Solid dispersions and physical mixtures were prepared and characterized by X-ray diffraction, infrared spectroscopy, electronic microscopy and dissolution rate studies. The characterization with X-ray diffraction showed a transition from the crystalline to the amorphous phase. A new phase near 50% Furosemide concentration with both types of carriers was present. From infrared spectroscopy strong interactions between amine and carbonyl groups from both the Furosemide and the polymers were found. Electronic microscopy analysis showed that the Furosemide changed its crystalline habit from needle to a new spherical phase, with diameter near to 1 microm. Solid dispersions were prepared in order to modify the system characteristics. The Furosemide dissolution rate was determined in order to follow the behavioural changes of the system. Scanning electron microscopy showed the presence of micro spheres within the polymeric matrix, and the channels formed due to the Furosemide dissolution inside the Eudragit: this fact modified the release pattern of the Furosemide system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675682     DOI: 10.1016/s0378-5173(99)00303-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.

Authors:  Ahmed Abd Elbary; Ahmed A Aboelwafa; Ibrahim M Al Sharabi
Journal:  AAPS PharmSciTech       Date:  2011-10-29       Impact factor: 3.246

Review 2.  Controlled release systems containing solid dispersions: strategies and mechanisms.

Authors:  Phuong Ha-Lien Tran; Thao Truong-Dinh Tran; Jun Bom Park; Beom-Jin Lee
Journal:  Pharm Res       Date:  2011-05-07       Impact factor: 4.200

3.  The application of modified flow-through cell apparatus for the assessment of chlorhexidine dihydrochloride release from lozenges containing sorbitol.

Authors:  Witold Musial; Jobst B Mielck
Journal:  AAPS PharmSciTech       Date:  2009-08-11       Impact factor: 3.246

4.  Design and optimization of diclofenac sodium controlled release solid dispersions by response surface methodology.

Authors:  H N Shivakumar; B G Desai; G Deshmukh
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

5.  Disintegration mediated controlled release supersaturating solid dispersion formulation of an insoluble drug: design, development, optimization, and in vitro evaluation.

Authors:  Sanjay Verma; Varma S Rudraraju
Journal:  AAPS PharmSciTech       Date:  2014-09-05       Impact factor: 3.246

6.  Development and Characterization of Eudragit®-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide.

Authors:  Marilena Vlachou; Stefanos Kikionis; Angeliki Siamidi; Sotiria Kyriakou; Andrew Tsotinis; Efstathia Ioannou; Vassilios Roussis
Journal:  Pharmaceutics       Date:  2019-09-17       Impact factor: 6.321

Review 7.  Insoluble Polymers in Solid Dispersions for Improving Bioavailability of Poorly Water-Soluble Drugs.

Authors:  Thao T D Tran; Phuong H L Tran
Journal:  Polymers (Basel)       Date:  2020-07-28       Impact factor: 4.329

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.